Intravenous thrombolysis for stroke in patients taking non-VKA oral anticoagulants: an update

MeSH terms

• ATP Binding Cassette Transporter, Subfamily B, Member 1 / antagonists & inhibitors
• Administration, Oral
• Aged
• Aged, 80 and over
• Anticoagulants / adverse effects*
• Anticoagulants / therapeutic use
• Antithrombins / adverse effects
• Antithrombins / therapeutic use
• Cerebral Hemorrhage / chemically induced*
• Cerebral Hemorrhage / epidemiology
• Contraindications
• Dabigatran / adverse effects*
• Dabigatran / therapeutic use
• Drug Administration Schedule
• Drug Interactions
• Endovascular Procedures
• Factor Xa Inhibitors / adverse effects
• Factor Xa Inhibitors / therapeutic use
• Female
• Humans
• Infusions, Intravenous
• Kidney Function Tests
• Male
• Middle Aged
• Practice Guidelines as Topic
• Pyrazoles / adverse effects*
• Pyrazoles / therapeutic use
• Pyridones / adverse effects*
• Pyridones / therapeutic use
• Retrospective Studies
• Rivaroxaban / adverse effects*
• Rivaroxaban / therapeutic use
• Stroke / drug therapy*
• Thrombectomy
• Thrombolytic Therapy / methods*
• Tissue Plasminogen Activator / administration & dosage*
• Tissue Plasminogen Activator / adverse effects
• Tissue Plasminogen Activator / therapeutic use